Mannkind (MNKD) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 214.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214.07% |
| Dec 31, 2025 | -705.43% |
| Sep 30, 2025 | 39.26% |
| Jun 30, 2025 | 111.34% |
| Mar 31, 2025 | 112.31% |
| Dec 31, 2024 | 710.82% |
| Sep 30, 2024 | -257.23% |
| Jun 30, 2024 | -1,606.00% |
| Mar 31, 2024 | -451.20% |
| Dec 31, 2023 | -152.60% |
| Sep 30, 2023 | -142.23% |
| Jun 30, 2023 | 81.21% |
| Mar 31, 2023 | 134.91% |
| Dec 31, 2022 | 219.33% |
| Sep 30, 2022 | 447.84% |
| Jun 30, 2022 | 101.80% |
| Mar 31, 2022 | -25.74% |
| Dec 31, 2021 | -180.78% |
| Sep 30, 2021 | 124,900.00% |
| Jun 30, 2021 | -74,921.33% |
| Mar 31, 2021 | -258.28% |
| Dec 31, 2020 | -2,117.82% |
| Sep 30, 2020 | -100.11% |
| Jun 30, 2020 | 89.04% |
| Mar 31, 2020 | 179.30% |
| Dec 31, 2019 | 17.21% |
| Mar 31, 2017 | 1,577.46% |
| Mar 31, 2016 | 73.19% |
| Dec 31, 2015 | 97.80% |
| Sep 30, 2015 | -431.80% |
| Jun 30, 2015 | 45.10% |
| Mar 31, 2015 | -198.30% |
| Dec 31, 2014 | -130.51% |
| Sep 30, 2014 | 5.65% |
| Jun 30, 2014 | -6,156.06% |
| Mar 31, 2014 | 3.43% |
| Dec 31, 2013 | -10,008.20% |
| Sep 30, 2013 | -85.48% |
| Jun 30, 2013 | -57.14% |
| Mar 31, 2013 | -401.37% |
| Dec 31, 2012 | 51.20% |
| Sep 30, 2012 | 79.12% |
| Jun 30, 2012 | 97.93% |
| Mar 31, 2012 | -115.86% |
| Dec 31, 2011 | 98.46% |
| Sep 30, 2011 | -233.48% |